Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

By sjmartinez • July 13, 2024

Narasaki Y, Kovesdy CP, You AS, Sumida K, Mallisetty Y, Surbhi S, Thomas F, Amin AN, Streja E, Kalantar-Zadeh K, Rhee CM. Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study. Lancet Reg Health Am. 2024 Jun 18;36:100814. doi: 10.1016/j.lana.2024.100814. PMID: 38993538; PMCID: PMC11237921.

Tags: Harbor UCLA, Nephrology, Publications, Veterans Administration

Large-scale multi-omics analyses in Hispanic/Latino populations identify genes for cardiometabolic traits

Petty LE, Chen HH, Frankel EG, Zhu W, Downie CG, Graff M, Lin P, Sharma P, Zhang X, Scartozzi AC, Roshani R, Landman JM, Boehnke[...]

Racial and Ethnic Differences in Long-Term Cardiovascular Mortality Among Women and Men From the CAC Consortium

Rosenblatt S, Blaha MJ, Blankstein R, Nasir K, Lin F, Yeboah-Kordieh Y, Berman DS, Miedema MD, Whelton SP, Rumberger J, Budoff MJ, Leipsic J, Shaw[...]

Optimizing optical coherence tomography to detect occult spermatozoa in rat testis after induced non-obstructive azoospermia

Yu L, Lue Y, Yang H, Liu J, Vega C, Ho K, Rajfer J, Wang C, Swerdloff R, Hyle Park B. Optimizing optical coherence tomography[...]